Community Gathering: Testing Solutions in Cancer

In the realm of contemporary cancer wellness, liquid biopsy has emerged as a pivotal player, reshaping the landscape of cancer screening and diagnostics. This month we are excited to welcome a great resource in blood-based diagnostics. Chad Bonfiglio will be joining us from Datar Genetics to share a presentation about non-invasive, blood-based technologies for cancer diagnosis, treatment, and remission monitoring. 

Who is Datar Cancer Genetics?

Datar Cancer Genetics is a global leader in developing blood-based diagnostics that can detect cancer early and offer non-invasive investigations for better treatment. At the forefront of this revolution are Datar's visionary scientists, who have devoted their expertise and ingenuity to craft unparalleled customized, non-invasive tests for the benefit of patients. By harnessing the power of molecular science and unraveling the mysteries held within Circulating Tumor Cells (CTCs) and DNA / RNA fragments, Datar has ushered in a new era of personalized cancer management through liquid biopsy. Their groundbreaking tests serve as the key to unlocking the potential of molecularly targeted therapies, providing a profound understanding of tumor heterogeneity and dynamic tumor biology. This information enables your team to devise optimum treatments for even the most difficult cases. To learn more about Datar visit https://datarpgx.com.

Times: 4:00pm-5:00pm Pacific / 5:00-6:00pm Mountain / 6:00-7:00pm Central / 7:00-8:00pm Eastern

If you have any questions, please contact us at info@healthnavs.com.